The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials.
about
A comparison of different antibiotic regimens for the treatment of infective endocarditisAntibiotic therapy for treatment of infective endocarditisBeta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsisIn vitro activity of daptomycin against Enterococcus faecalis under various conditions of growth-phases, inoculum and pHAntibiotic stewardship in the intensive care unit.Success of ampicillin plus ceftriaxone rescue therapy for a relapse of Enterococcus faecalis native-valve endocarditis and in vitro data on double beta-lactam activity.New perspectives of infections in cardiovascular diseaseIncidence, risk factors and prediction of post-operative acute kidney injury following cardiac surgery for active infective endocarditis: an observational study.Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1).Impact of definitive therapy with beta-lactam monotherapy or combination with an aminoglycoside or a quinolone for Pseudomonas aeruginosa bacteremia.Risk of AKI with gentamicin as surgical prophylaxis.Postpartum culture negative endocarditis: a case report and review of the current guidelinesR-CHOP versus R-CVP in the treatment of follicular lymphoma: a meta-analysis and critical appraisal of current literature.Acute infective endocarditisAminoglycoside drugs in clinical practice: an evidence-based approach.Pharmacological rationale for antibiotic treatment of intra-abdominal infections.Infective endocarditis--prophylaxis, diagnostic criteria, and treatment.Fluorescent aminoglycosides reveal intracellular trafficking routes in mechanosensory hair cells.The efficacy and safety of antibiotic combination therapy for infections caused by Gram-positive and Gram-negative organisms.Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy.Rational use of aminoglycosides--review and recommendations by the Swedish Reference Group for Antibiotics (SRGA).Aminoglycoside therapy in infectious diseases.Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: a systematic review.Aminoglycoside use in a pediatric hospital: there is room for improvement-a before/after study.[Diagnosis and treatment of infective endocarditis. Current ESC guidelines].Assessment by time-kill methodology of the synergistic effects of oritavancin in combination with other antimicrobial agents against Staphylococcus aureus.The optimal aminoglycoside and its dosage for the treatment of severe Enterococcus faecalis infection. An experimental study in the rabbit endocarditis model.A 10-year survey of blood culture negative endocarditis in Sweden: aminoglycoside therapy is important for survival.Prevention and Therapy of Acute Kidney Injury in the Developing World.Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?
P2860
Q24185887-60199C68-B106-4EFA-961F-E7DD201351ADQ24198788-68380551-21DA-43C4-A7E6-FB1BE4777FDDQ24201201-C81B9101-5837-4595-99C7-F7A3F3654F4FQ28488311-38211AAE-1389-48D1-8884-05947CA28612Q30408712-76B607C4-A1B8-4EAC-AFD0-9018AE246C5FQ33365986-6AF6B6D8-4AB0-44E3-9447-F81F511FCB8CQ33587960-20430D42-DCA8-4439-979A-4B54ABCE7D2BQ33752838-6132D5D4-CD20-46F1-98E6-CC96132CBBCCQ33753500-41E30D7D-3E66-4902-9EE6-5A3D153A195DQ34064473-67CF09B5-5B7C-4D51-BCD2-938827A5F071Q34427714-E00FA958-9473-49B0-84C2-335FF8396CF7Q35295593-BC20DDFB-876C-497F-945D-160D0FDB1E1CQ37158679-2652FB48-8C6B-4A09-9D7F-50581B595030Q37305018-1AC72601-A928-46A7-B3D8-83DC7B22C057Q37331044-37C051D7-57A9-494E-9A97-82D770AC8916Q37557851-A0F1EB1C-3521-4B02-A5BD-7E313D9346DBQ37591949-15B8747F-68B0-4723-9318-3E3C71C10121Q37610685-3011156E-BE79-4163-AFC6-4CACC2C9B182Q37954711-27A30D45-3392-4906-9002-CDD795E728C7Q37956597-281FA5FD-CC52-4CF2-89BE-754068F36841Q38070006-3C0EE362-B203-43B5-BD5B-45835752CF94Q38112810-FF609C6B-57E1-4E0D-8742-28BD3CC40360Q38212031-44D766AE-D243-4786-A7A8-337FA373DAC7Q40081223-906FD1C0-9A11-44F0-BEB4-501BACB65F79Q42824408-57821E2A-F14C-4335-85AB-D5F1AE1530D4Q43189837-7B07C936-C4A3-4F72-BC69-C0AC1EC39D34Q44964829-F73ABD78-AF5E-47FE-865E-2C12F1C324B4Q46709397-8F179683-7640-4306-963A-D95B8072BECAQ47361874-C8210DD2-03BD-4DC4-BB5F-B49230ABE7E4Q52655525-CB86EADC-A341-465D-8EDD-356ADF1926E0
P2860
The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
The role of aminoglycosides in ...... nalysis of comparative trials.
@ast
The role of aminoglycosides in ...... nalysis of comparative trials.
@en
type
label
The role of aminoglycosides in ...... nalysis of comparative trials.
@ast
The role of aminoglycosides in ...... nalysis of comparative trials.
@en
prefLabel
The role of aminoglycosides in ...... nalysis of comparative trials.
@ast
The role of aminoglycosides in ...... nalysis of comparative trials.
@en
P50
P356
P1476
The role of aminoglycosides in ...... nalysis of comparative trials.
@en
P304
P356
10.1093/JAC/DKL044
P407
P577
2006-02-24T00:00:00Z